Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies Source: Eur Respir J 2008; 31: 70-77 Year: 2008
Investigation of alarmins, interleukin (IL-)23 and IL-36 sputum levels in chronic airway obstructive diseases. Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis Source: Eur Respir J 2001; 17: 1112-1119 Year: 2001
Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 640-646 Year: 2005
Levels of CC-chemokines (MCP-1, MIP-1α, MIP-1β) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis Source: Eur Respir J 2001; 18: Suppl. 33, 194s Year: 2001
Induced sputum IL-13 concentration in asthma, COPD and eosinophilic bronchitis Source: Eur Respir J 2004; 24: Suppl. 48, 594s Year: 2004
Chronic bronchitis: a risk factor for bronchial infection Source: Eur Respir Monogr 2013; 60: 18-26 Year: 2013
Pathology, inflammation and cytokines of severe asthma Source: Eur Respir Mon 2011; 51: 97-106 Year: 2011
Interleukin 18: implication in airway inflammation and pulmonary function in healthy and bronchitis type COPD smokers Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008
CC10 and TIMP1 levels in induced sputum of smokers who developed chronic airflow impairment Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking Year: 2005
Dynamics of the inflammatory process by determining the IL-6 content in bronchoalveolar fluid in chronic bronchitis and chronic bronchitis complicated by secondary bronchiectasis Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015
Bronchial vascularity in the airways of chronic bronchitis and COPD smokers Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010
Chronic sputum production and airway inflammation in COPD in the stable state and at exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005
Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 325-331 Year: 2002
Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008
Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design Source: Eur Respir J 2006; 27: 293-299 Year: 2006
Role of tissue kallikrein 1 in late phase bronchoconstriction and airway hyperresponsiveness Source: Annual Congress 2006 - Basic mechanisms of allergic airways inflammation Year: 2006
Chronic sputum production in COPD is a marker for airway inflammation and colonisation Source: Eur Respir J 2004; 24: Suppl. 48, 306s Year: 2004
Airway epithelial inflammatory responses and clinical parameters in COPD Source: Eur Respir J 2003; 22: 94-99 Year: 2003
Expression of type 1 and type 2 cytokines in central airways of smokers with chronic bronchitis Source: Eur Respir J 2001; 18: Suppl. 33, 74s Year: 2001